Cardiff Oncology, Inc. (CRDF) Social Stream

Featured Post From StockTwits About CRDF

This is just my opinion, and it's only slightly rooted in what I believe to be factual. So take my speculation for what it might be worth.

I think that what might make $CRDF stand out in the collective of stocks that have plays in the mutant KRAS niche is that PLK1 is involved in so many pieces of the cell cycle that it seems reasonable to expect that onvansertib will play out differently in cancers that begin to display escape mechanisms found frequently when mutated KRAS gene expressions are suppressed.